#China bioprocess instruments | Explore Tumblr posts and blogs

credenceresearchdotblog · 1 month ago

Text

The coenzyme A market is projected to grow from USD 100,110 million in 2024 to an estimated USD 216,160.3 million by 2032, registering a compound annual growth rate (CAGR) of 10.1% during the forecast period.Coenzyme A (CoA) plays a critical role in numerous metabolic processes, serving as a carrier of acyl groups in enzymatic reactions within living organisms. Its significance in energy production, fatty acid synthesis, and the Krebs cycle makes CoA a vital compound in biochemistry, pharmacology, and biotechnology. The Coenzyme A market has been growing steadily, driven by its applications in pharmaceuticals, nutraceuticals, cosmetics, and research sectors.

Browse the full report https://www.credenceresearch.com/report/coenzyme-a-market

Market Overview

The global Coenzyme A market is primarily fueled by increasing demand in the pharmaceutical and biotechnology industries. CoA derivatives, such as acetyl-CoA and succinyl-CoA, are instrumental in drug discovery and metabolic research.

The market is segmented based on: - Application: Pharmaceuticals, nutraceuticals, cosmetics, and research. - Region: North America, Europe, Asia-Pacific, and the rest of the world.

The Asia-Pacific region, particularly countries like China and India, has shown significant growth due to increasing research activities and industrial applications.

Key Market Drivers

1. Pharmaceutical Applications Coenzyme A is a crucial ingredient in the synthesis of certain medications, particularly those targeting metabolic disorders. Its role in regulating energy metabolism has opened avenues for therapies addressing diabetes, obesity, and neurodegenerative diseases.

2. Biotechnology Advancements With the growth of biotechnology, Coenzyme A is extensively used in enzyme-catalyzed reactions for biocatalysis and synthetic biology. This has boosted its demand in industrial and academic research.

3. Nutraceuticals and Functional Foods As consumer awareness about health and wellness grows, the demand for CoA in nutraceuticals has risen. It is marketed for its potential benefits in energy metabolism, improving skin health, and reducing oxidative stress.

4. Cosmetic Industry Expansion Coenzyme A derivatives are gaining popularity in the cosmetic industry due to their anti-aging properties. They help in repairing skin damage, reducing inflammation, and improving skin elasticity.

Challenges in the Coenzyme A Market

Despite its wide-ranging applications, the Coenzyme A market faces certain challenges:

- High Production Costs: The biosynthesis of CoA involves complex processes, leading to high production and purification costs. - Regulatory Hurdles: Stringent regulations in the pharmaceutical and nutraceutical industries pose challenges for market entry and approval. - Competition from Alternatives: Synthetic derivatives and alternative compounds can sometimes substitute Coenzyme A, limiting its market share.

Opportunities for Growth

1. R&D Investments Ongoing research in metabolic engineering and synthetic biology is creating innovative pathways for CoA production. This could lead to cost-effective manufacturing and broader applications.

2. Personalized Medicine Coenzyme A's role in metabolic pathways positions it as a key component in personalized medicine, especially for treating metabolic disorders and rare diseases.

3. Emerging Markets Developing economies are witnessing increased investments in biotechnology and pharmaceuticals. These markets offer untapped opportunities for CoA producers.

4. Green Chemistry The integration of CoA in environmentally sustainable bioprocesses aligns with the growing trend of green chemistry, opening doors for new industrial applications.

Future Outlook

The Coenzyme A market is poised for significant growth, with advancements in biotechnology and increasing applications in various industries. As production techniques become more cost-effective and regulatory pathways streamlined, the market is expected to witness wider adoption.

Innovations in synthetic biology and metabolic engineering will likely reshape the market, enabling sustainable production and new applications. Furthermore, the rising interest in personalized medicine and functional foods will continue to drive demand for CoA derivatives.

Key Player Analysis:

BASF

Cayman Chemical

Creative Enzymes

DSM

Lee BioSolutions, Inc.

Merck KGaA

PerkinElmer, Inc.

Sigma-Aldrich

Thermo Fisher Scientific, Inc.

Avanti Polar Lipids, Inc.

Segmentation:

By Type

Lithium Salt

Sodium Salt

Free Acid

Others

By Application

Biotechnology Research

Dietary Supplement

Therapeutic

Others

By Geography

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report https://www.credenceresearch.com/report/coenzyme-a-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

themarketinsights · 1 year ago

Text

Separation Systems for Commercial Biotechnology Market May Set Huge Growth by 2028

Latest released the research study on Global Separation Systems for Commercial Biotechnology Market, offers a detailed overview of the factors influencing the global business scope. Separation Systems for Commercial Biotechnology Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Separation Systems for Commercial Biotechnology The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Thermo Fisher Scientific (United States), Danaher Corporation (United States), Agilent Technologies (United States), Waters Corporation (United States), Shimadzu Corporation (Japan), Bio-Rad Laboratories (United States), Merck & Co., Inc. (United States), QIAGEN (Germany), Sartorius (Germany), PerkinElmer, Inc. (United States)

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/17512-global-separation-systems-for-commercial-biotechnology-market

Separation Systems for Commercial Biotechnology Market Definition:

Bioseparation systems are used for the purification and separation of biological products and the equipment used for the separation of biological material from complex mixture or solution includes chromatography, membrane filters, and centrifuges. HPLC is one of the most commonly used separative techniques and also one of the fastest-growing instrumentation fields in the world. HPLCS are considered standard analytical tools in the laboratory to accurately isolate and purify organic molecules, drugs, and some peptide hormones. The United States is a recognized leader in analytical instrumentation used in biological research and thus stands at the forefront of many of the technical innovations being made in the bioprocess field.

Market Trend:

Ultrafiltration and Other Filtration Systems

HPLCS to Monitor Bioprocesses and Purify Large Quantities of Proteins such as Leukocyte Interferon

Market Drivers:

The growing number of biotech firms with huge investments in research and development is the key driving factor for the growth of the market.

Stringent Government Rules & Regulations

Technological Advancement in the Biotechnology Sector

Market Opportunities:

The use of rDNA technology to produce low-volume, high value-added products as well as high-volume products has greatly increased the need to develop more economic bioprocesses.

The Global Separation Systems for Commercial Biotechnology Market segments and Market Data Break Down are illuminated below:

by Application (Vaccines, Hormones, Proteins, Enzymes, Others), End-User (Pharmaceutical, Food & Cosmetics, Agriculture, Life Sciences Research, Others), Method (Liquid Chromatography, Membrane Filtration, Electrophoresis, Niche Separation, Centrifugation, Lab-on-a-Chip, Others)

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/17512-global-separation-systems-for-commercial-biotechnology-market

Strategic Points Covered in Table of Content of Global Separation Systems for Commercial Biotechnology Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Separation Systems for Commercial Biotechnology market

Chapter 2: Exclusive Summary – the basic information of the Separation Systems for Commercial Biotechnology Market.

Chapter 3: Displayingthe Market Dynamics- Drivers, Trends and Challenges of the Separation Systems for Commercial Biotechnology

Chapter 4: Presenting the Separation Systems for Commercial Biotechnology Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying market size by Type, End User and Region 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Separation Systems for Commercial Biotechnology market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2021-2026).

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Separation Systems for Commercial Biotechnology Market is a valuable source of guidance for individuals and companies in decision framework.

Data Sources & Methodology The primary sources involves the industry experts from the Global Separation Systems for Commercial Biotechnology Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

For Early Buyers | Get Up to 20% Discount on This Premium Report: https://www.advancemarketanalytics.com/request-discount/17512-global-separation-systems-for-commercial-biotechnology-market

What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us: Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837

0 notes

healthcare-reports · 7 years ago

Text

China Bioprocess Instruments Market Analysis and Forecast Report, 2014 to 2024

The China Bioprocess Instruments Market is expected to reach USD 3.06 billion by 2024 owing to the improving economy, rising aging population and increasing prevalence of chronic diseases. Moreover, increasing demand for single-use instruments in disposable applications is anticipated to augment the growth over the projected period.

China was the second largest pharmaceutical market in the world, expected to grow USD 173 billion by 2024, growing at a CAGR of 9.1% owing to the requirement of medication & drugs to cure deadly diseases. Huge investment in biotechnology will primarily drive the growth of the market, as pharma companies deal in innovations for developing medicines and drugs in line with the increasing prevalence of diseases.

Browse Details of Report @ https://www.hexaresearch.com/research-report/china-bioprocess-instruments-market

With the patents of numerous biopharmaceutical products expiring by 2016, the market is anticipated to provide a lucrative opportunity for contract manufacturers operating in the region. Approval of the trail plan for new drug marketing authorization holder (MAH) in 2016 to produce, conduct clinical trials, and market the products is expected to provide an impetus to the growth of the industry over the next few years.

Increasing demand for bioprocess instruments in the pharmaceutical, research & development, industrial and medical laboratories coupled with the increasing number of these facilities is expected to result in the growth of the market. Change in lifestyle & food consuming habits, and growing levels of air & water pollution have led to increasing occurrence of disease including obesity which has resulted in a rising number of patients diagnosed with cancer, heart disease, diabetes and other chronic conditions. Thus, the healthcare sector is anticipated to create demand for treatment and laboratory services, which will result in the growth of bioprocess instruments market over the forecast period.

Stringent regulatory policies and the high cost of instruments are likely to restrain the bioprocess instruments market in China. The government has been focusing on reducing the fragmentation in the industry by consolidating manufacturers that lack standards in production with larger companies. This move will help in preventing the quality risks and sub-par manufacturers entering the market. Shortage of skilled labor is another challenge in the growth of bioprocessing industry.

Koninklijke Philips N.V., Thermo Fisher Scientific Inc. and Becton, Dickinson and Company were the top three companies in the market in China in 2016. Companies are extensively investing in R&D for innovation and new product development. In addition, companies are adopting the strategy of merger and acquisition to expand their product portfolio.

Hexa Research has segmented the China bioprocess instruments market based on type:

Segmentation by type, 2014 - 2024 (USD Million)

• Cell Expansion

• Flow Cytometry

• Biologics Safety Testing

• Cell Line Development

• Tangential Flow Filtration

• Cell Counters

• Virus Filtration

• Cell Culture

• Pyrogen Testing

• Single-Use Bioprocessing

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: [email protected]

Website - https://www.hexaresearch.com/

#China bioprocess instruments market #China bioprocess instrument market #China bioprocess instrument #China bioprocess instruments #China bioprocess instruments industry #bioprocess instruments market #bioprocess instruments #bioprocess instruments industry

0 notes

metiresearchinfo · 3 years ago

Text

Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography - Forecast to 2028

The continuous bioprocessing market is expected to grow at a CAGR of 23.0% from 2021 to reach $429.12 million by 2028. Continuous bioprocessing involves manufacturing biopharmaceuticals where continuous unit operations are physically connected with minimal hold volume. Some of the major factors driving the growth of this market include the growing demand for biopharmaceuticals, technological developments in continuous bioprocessing, product launches in the area of continuous bioprocessing, and global initiatives supporting the adoption of biopharmaceuticals. The growing shift towards the bioprocess 4.0 industry, growing opportunities in developing countries, and rising preference for personalized medicine are expected to create significant market growth opportunities.

COVID-19 Impact Assessment

The COVID-19 pandemic has affected most industries, including the biopharma industry. Changes in the bio/pharmaceutical industry have accelerated as a response to the ongoing COVID-19 pandemic. The biopharma industry is adopting improved strategies to tackle the current pandemic, prepare for future pandemics, and minimize supply disruptions. The industry is witnessing partnerships and collaborations focused on accelerating R&D and implementing flexible, rapid, and modular production processes to speed up the products’ time to market. Such factors are projected to drive the demand for continuous bioprocessing amid the COVID-19 pandemic.

Pharma manufacturers are investing in vaccine development and production. For instance, in June 2020, the Serum Institute of India (India) announced an investment of USD 100 million in the COVID-19 vaccine being developed at Oxford University, in partnership with AstraZeneca Plc. (U.K.), to ensure equitable supply of the AZD1222 vaccine doses to India as well as other low-and-middle-income countries. In December 2020, China-based Sinovac Biotech Ltd. received an investment of USD 515 million from local firm Sino Biopharmaceutical to accelerate the production of a COVID-19 vaccine candidate. Such initiatives are expected to create favorable market opportunities.

As per the Global Vaccine Market Report released by WHO in December 2019, the annual demand for vaccines had reached 3.5 billion doses in 2018. However, with the emergence of COVID-19, this number is expected to reach 9 billion doses of different vaccine modalities by the end of 2021. This sizeable requirement is expected to generate novel approaches like continuous bioprocessing and the use of single-use technologies.

However, the global spread of COVID-19 also adversely impacted operations, sales, and delivery & supply chains. Many countries implemented national lockdowns, shelter-in-place, curfews, travel restrictions, and isolation measures delaying distributions and affecting supply chains of the necessary instruments and consumables, negatively impacting continuous bioprocessing.

Thus, apart from few supply disruptions and operational challenges during the first phase of the pandemic, the overall impact of COVID-19 is expected to be positive on the market with growing pressure from the policymakers to develop novel vaccines and therapies cost-effectively.

Click here to: Get Free Request Sample Copy of this report

Various initiatives supporting the adoption of biopharmaceuticals is projected to drive the adoption of continuous bioprocessing

The global biosimilars market is fast-growing and possesses strong economic value. Pricing for biosimilars is usually 30-50% lower than that of biologics. This cost advantage gives greater access to biosimilars, further lowering the health expenditure in many countries. As per the Center for Medical Economics and Innovation at the Pacific Research Institute (PRI), U.S., expanding the use of biosimilars to treat serious illnesses like autoimmune diseases or cancer can help reduce the out-of-pocket spending by 17% for the patient.

Between 2017-2024, it is projected that near about biologics worth USD 100 billion will go off patent, creating opportunities for the biosimilars. The U.S. FDA is expecting the review of over 66 biosimilars as 66 biologics are going off-patent between 2020 and 2025. Knowing the high potential in the biosimilars business, market players such as Mylan N.V (U.S.), Biocon Limited (India), and Aurobindo Pharma Limited (India) are investing in biosimilars. Growing developments in the space of biosimilars are further fueled by supportive initiatives across various countries worldwide.

In February 2020, the U.S. FDA transitioned to a new regulatory pathway to boost the competition between biological products. The U.S. FDA and the Federal Trade Commission (FTC) signed a joint statement regarding enhanced collaboration to support a robust marketplace for biological products like biosimilars and interchangeable products.

China and India are among the leading countries in terms of the development and commercialization of biosimilars. The Chinese government offers multiple initiatives facilitating the development and adoption of biosimilars. The Marketing Authorization Holder (MAH) pilot scheme was launched in China, allowing license holders to sell drugs in China using a contract manufacturer, driving innovations and accelerating the speed at which international companies can introduce products in China, facilitating the growth of CDMOs. Such initiatives are driving the adoption of biosimilars globally, thereby positively impacting the demand for continuous bioprocessing technologies.

Active research in the area of personalized therapies to create several opportunities for market growth

Growing advances in proteomic and genomic sciences have boosted the emergence of personalized therapies. The wave of personalized medicines has entered a mainstream clinical approach, changing the identification, classification, or treatment of diseases. The recognition for personalized medicines is growing among the policymakers, driving the innovative approaches of developing and producing personalized therapies. Continuous bioprocessing and greater accuracy through data analytics and monitoring allow for higher concentrations of next-generation biologics drug dosages, enabling more personalized and effective medicines in potentially smaller/less frequent administration and dosages.

With the pharmaceutical industry moving towards the development of personalized therapies, new manufacturing approaches are being adopted to meet the growing market demand. Advancing continuous bioprocessing has emerged as one of the innovative approaches for manufacturing therapies cost-effectively and on a relatively small scale, offering multiple advantages.

Key Findings in the Global Continuous Bioprocessing Market Study:

In 2020, the filtration systems and consumables segment accounted for the largest share of the market

Based on product, the continuous bioprocessing market is segmented into filtration systems & consumables; chromatography systems & consumables; bioreactors; sterilizers; centrifuges; incubators & shakers; mixing systems; cell culture media, buffers, and reagents; and other products. The growing demand for higher standards of filter operations in biopharma manufacturing is one of the major drivers for the growth of this segment. Filter manufacturers are developing filtration technologies for continuous bioprocessing to achieve both separation and purification through a combination of physical removal capabilities of filtration and size exclusion.

The research & development segment is projected to grow at the highest CAGR during the forecast period

Based on application, the continuous bioprocessing market is segmented into commercial and R&D. The rising focus of R&D to develop vaccines and suitable therapies for COVID-19 and growing relevance of mAb manufacturing for the treatment of various diseases are driving the market growth. The R&D in cell and gene therapy is also accelerated, with over 900 candidates in clinical studies. Facility expansions of CROs or CDMOs to advance research in these areas are expected to boost market growth.

In 2020, the pharmaceutical and biotechnology companies segment dominated the global continuous bioprocessing market

Based on end user, the continuous bioprocessing market is segmented into pharmaceutical and biotechnology companies, CDMOs & CMOs, and academic and research institutes. Pharma and biopharma manufacturers are shifting from batch to continuous processing. This process provides considerable benefits to manufacturers by being more cost-effective, requiring less infrastructure, less space, less investment, less staff, all while manufacturing products in the same or perhaps less time than traditional batch methods.

Asia-Pacific: Fastest growing regional market

Based on region, the market is segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa. The gradually emerging landscape of biopharmaceuticals in Asian countries, CDMO expansions, developments in bioprocessing technologies and partnerships, and collaborations among market players for biopharma manufacturing drives the market growth in Asia-Pacific.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past three years. The key players profiled in the global continuous bioprocessing market report are 3M (U.S.), Cytiva (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), and Bionet (Spain).

Scope of the Report:

Continuous Bioprocessing Market, by Product

Filtration Systems and Consumables

Chromatography Systems and Consumables

Bioreactors

Sterilizers

Centrifuges

Incubators and Shakers

Mixing Systems

Cell Culture Media, Buffers, and Reagents

Other instruments and consumables

Continuous Bioprocessing Market, by Application

Commercial

R&D

Vaccines

mAb production

Recombinant Protein Production

Cell and Gene Therapy Production

Continuous Bioprocessing Market, by End User

Pharmaceutical and Biotechnology Companies

Contract Development and Manufacturing Organizations and Contract Research Organizations

Academic and Research Institutes

Continuous Bioprocessing Market, by Geography

North America

Europe

Asia-Pacific (APAC)

Latin America

Middle East & Africa

U.S.

Canada

Germany

U.K.

France

Italy

Spain

Rest of Europe (RoE)

China

Japan

India

Rest of APAC (RoAPAC)

0 notes

techsciresearch · 3 years ago

Text

Plant Based Biomanufacturing Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research

Advancing technology in botanical medicine is driving the growth in Global Plant Based Biomanufacturing Market in the forecast period, 2022-2026.

According to TechSci Research report, “Global Plant Based Biomanufacturing Market By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others) By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others) By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others) By Region, Competition Forecast & Opportunities, 2026”, the global plant based biomanufacturing market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of rising demand for food and beverages containing organic and herbal ingredient.

Surging demand from the health-conscious consumers has driven the biotechnological research to be dedicated toward finding such product. Number of biotechnological studies and research institutes are rapidly increasing and thus driving the growth of the global plant based biomanufacturing market in the upcoming five years. Increasing number of upcoming plant-based proteins and development in the studies of recombinant protein that are plant based, is also supporting the growth of the global plant based biomanufacturing market in the next five years.

Plant based biomanufacturing includes protein manufacturing processes through recombinant protein production. These proteins include protein biopolymers, industrial proteins and enzymes, and therapeutic proteins. The production processes involve a narrowing diversity of bioreactors for cell, hairy root, microalgae, and moss cultivation. Direct use of cultivated plant cells, whole or minimally processed plants, or plant parts (e.g., seeds, dried leaves) is in development for industrial/bioenergy applications as well as for therapeutics and vaccines and play a vital role in bio-pharmaceutical productions.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on " Global Plant based biomanufacturing Market"

https://www.techsciresearch.com/report/plant-based-biomanufacturing-market/7734.html

The global plant based biomanufacturing is segmented by product type, technology, source, end user, competitional landscape, and regional distribution. Based on technology, the market is further divided between upstream biomanufacturing and downstream biomanufacturing. Upstream biomanufacturing is the process of growing protein products by either bacterial culture of cell culture. Plant cells if used for these cultures are termed as upstream plant based biomanufacturing. These manufactured proteins are specifically laboratory designed to combat various kind of diseases.

In the upstream biomanufacturing processes, the biological materials are obtained from outside source or inoculated and grown in culture, under controlled conditions. In the downstream biomanufacturing process the biological products are harvested, tested, purified, and packaged. Plant-based biomanufacturing depending on the recombinant protein processes can either be done through upstream or downstream technology. The advantages of these biotechnological processes is anticipated to drive the growth of the global plant based biomanufacturing market in the upcoming five years.

Based on product type, the market is further bifurcated into antibodies, vaccines, proteins, biologics, enzyme, and others. Biologics are anticipated to hold the largest revenue shares of the market and dominate the segment in the next five years on the account of changing consumer preferences to more nutritional and herbal products. Consistent research and advancing plant based medicinal nutrient is also driving the growth of the global plant based biomanufacturing market in the upcoming five years.

Vaccines are expected to show fastest growing CAGR in the next five years on the account of rapidly evolving drug development procedures that have plant based recombinant proteins. Also, the recent pandemic situation due to COVID-19 has enhanced the healthcare industry inclination toward finding plant-based vaccines for the protection against deadly viruses. These factors are actively influencing the growth of the global plant based biomanufacturing market in the future five years of forecast until 2026.

Holding the major shares of the global plant based biomanufacturing market are Pfizer, Inc., Aimmune Therapeutics Inc. (Nestle), Medicago, Inc., Kentucky BioProcessing, Inc., iBio, Inc., PlantForm Corporation, Ventria Bioscience Inc., Protalix Biotherapeutics, Inc., Planet Biotechnology Inc., Zea Biosciences Corp., among others. Market players are actively involved in the research and technological development in the product developments.

The advanced technology has made it possible for the industry to provide excellent services through plant based biomanufacturing. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7734

Customers can also request for 10% free customization on this report.

“Asia Pacific region is expected to register a substantial growth with the fastest growing CAGR on the account of rapidly increasing biotechnological research in the countries like India, China, South Korea, and China. The evolution of medical, healthcare, and botanical sciences is also apprehensive of the future growth of the global plant based biomanufacturing market. New drug development, effective diagnostics, nutrient based food are some of the major products of plant based biomanufacturing that will enhance the growth mapping of the market. Consistent research and technological advancement may support the new market players trying to enter the market in the future five years and in their brand establishment,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Plant Based Biomanufacturing Market By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others) By Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed, Leaf, Others) By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global plant based biomanufacturing and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global plant based biomanufacturing market.

Browse Related Reports:

Global Neuroendocrine Tumor Market By Therapy Type (Chemotherapy, Immunotherapy, Hormonal Therapy, Surgery, Targeted Therapy, Others) By Mechanism of Action (Somatostatin Analogs, Tyrosine Kinase Inhibitor, Peptide receptor radionuclide, Alfa-interferon, Proton pump inhibitors, Others) By Drug Type (Everolimus, Sunitib malate, Lorlatinib, Nivolumab, Bevacizumab, Others) By Indication (Gastrointestinal NET, Lung NET, Pancreatic NET, Appendiceal NET, Others) By Route of Administration (Oral, Parenteral, Others) By End User (Hospitals, Ambulatory Surgical Centers, Oncology Centers, Others (GI centers, Cardio-thoracic centers, NET centers) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/neuroendocrine-tumor-market/7606.html

Global Nanopore Sequencing Market By Product (Consumables v/s Instruments), By Nucleotide Sequenced (DNA v/s RNA), By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing), By Type of Nanopore (Solid State, Biological, Hybrid), By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research), By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes), By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/nanopore-sequencing-market/7677.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Plant Based Biomanufacturing Market #Global Plant Based Biomanufacturing Market #Healthcare #Consumer Healthcare #Plant Based Biomanufacturing Market Size #Plant Based Biomanufacturing Market Forecast

1 note · View note

techscimarketresearch · 3 years ago

Text

Plant Based Biomanufacturing Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research

Advancing technology in botanical medicine is driving the growth in Global Plant Based Biomanufacturing Market in the forecast period, 2022-2026.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on " Global Plant based biomanufacturing Market"

https://www.techsciresearch.com/report/plant-based-biomanufacturing-market/7734.html

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7734

Customers can also request for 10% free customization on this report.

Browse Related Reports:

https://www.techsciresearch.com/report/neuroendocrine-tumor-market/7606.html

https://www.techsciresearch.com/report/nanopore-sequencing-market/7677.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Global Plant Based Biomanufacturing Market #Plant Based Biomanufacturing Market #Plant Based Biomanufacturing Market Size #Plant Based Biomanufacturing Market Forecast #Healthcare #Consumer Healthcare

1 note · View note

sambilling · 4 years ago

Text

membrane Chromatography Market Analysis and Forecast for 2021

Membrane Chromatography is an analytical technology in the field of bioprocess engineering that is commonly applied in the separation of large molecules like viruses and microbial agents, for the isolation of microorganisms and in polishing processes for the elimination of genetic material (DNA). It is often used for applications requiring separation of monoclonal antibodies against various single or double helical proteins. This method can be used at the stage of infection to separate virus and other pathogens from infective tissue or in the field of genomics to study the genetic differences of various species. It has great potential in many fields of research and can be very useful.

The membrane chromatography Market Research report and forecasts for the next five years are presented in the Global membrane chromatography Market Research Study of 2021. This is the forecast period of the major markets across all of the membrane chromatography Processes and their applications. The Global membrane chromatography Market Research Study of 2021 presents data on the growth and data on the percentage of new process stages in membrane chromatography, applications growth, applications trends and other market and technological developments in the field of membrane chromatography.

The growth of the market. This data shows that there are new advanced equipment technologies and software applications which can provide higher performance at reduced cost. The membrane chromatography Market Research for the coming five years shows strong demand for systems and methodologies with greater throughput, more process cycles with reduced costs and improved separation and mobility. Some of the most important markets and regions where the membrane chromatography Market Research will be conducted include: Biotechnological Plants, Nanotechnology, Food & Drug Administration, Colleges and Universities, Infuse Electron Microscopy, Biotechnological Producers and Others. The global membrane chromatography Market Research also reveals the trend of investment in the market by biotechnology organizations, colleges and universities and other medical centers and institutions.

The main drivers behind the growth and forecast of this market are the following: The forecast provides for expanding coverage in major regions and countries. The market will continue to expand globally due to the increasing number of uses for its technologies in many applications. The expansion will further increase in the coming five years due to: the growth of the biotechnological industry and demand for improved analytical methodologies. There is also an increase in the number of applications requiring higher resolution and faster methodologies.

The growth of the market. In this forecast period, membrane chromatography is used for the analysis of a wide range of chemical compounds with high analytical potential. The membrane chromatography Market Research data also indicates the trend of investment in membrane chromatography by biotechnological and pharmaceutical organizations. As a result of these investments, there is expected to be continued growth in the coming years. For the large-scale firms, there is predicted to be continued growth in both the markets with significant concentration in some of the regions.

This market report discusses the membrane chromatography Market Research data for analysis and forecasts for the coming year. It includes a market forecast for the markets including industrial and advanced laboratory instruments, instrumentation, analytical methods, instrumentation design, process optimization, analytical methodologies and the applications. This market report also includes the summary of selected highlights of membrane chromatography Market Development Criteria for the coming year 2021. This analysis and forecast are the basis for the strategic decisions for the growth of the membrane chromatography market in 2021.

The research team projects that the Membrane Chromatography Consumables market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players: Merck Restek Corporation 3M Sartorius AG Cole-Parmer Instrument Company GL Sciences Inc. GVS Group Asahi Kasei Corporation Thermo Fisher Scientific Purilogics Membrane Solutions LLC Regis Technologies Inc

By Type Syringe Filters Filter Plates Spin Columns Membrane Discs and Sheets Other

By Application Hospital Clinic Others

By Regions/Countries: North America United States Canada Mexico

East Asia China Japan South Korea

Europe Germany United Kingdom France Italy Russia Spain Netherlands Switzerland Poland

South Asia India Pakistan Bangladesh

Southeast Asia Indonesia Thailand Singapore Malaysia Philippines Vietnam Myanmar

Middle East Turkey Saudi Arabia Iran United Arab Emirates Israel Iraq Qatar Kuwait Oman

Africa Nigeria South Africa Egypt Algeria Morocoo

Oceania Australia New Zealand

South America Brazil Argentina Colombia Chile Venezuela Peru Puerto Rico Ecuador

Rest of the World Kazakhstan

Points Covered in The Report The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc. The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast. The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail. Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements. The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Membrane Chromatography Consumables 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast. Market Analysis by Product Type: The report covers majority Product Types in the Membrane Chromatography Consumables Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD). Markat Analysis by Application Type: Based on the Membrane Chromatography Consumables Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and Drivers: Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Membrane Chromatography Consumables market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

For more details contact as https://www.reportmines.com/contact-us.php

0 notes

marketanalysisdata · 4 years ago

Text

Liquid Handling Technology Market Size, Distributor Analysis And Applications Insights till 2025

25th May 2021 – Global Liquid Handling Technology Market is expected to reach USD 6.99 billion by 2025. Liquid Handling Technology plays important role in research laboratories for experiments like drug screening, gene sequencing, antibody testing, and protein crystallization. It includes the movement of liquid reagents through the varied range of large-scale robotic stages to hand held single channel pipettes. These are the important technologies in order to enhance accuracy and performance for the user. The Liquid Handling Technology Market is estimated to grow at a significant CAGR of 8.5% over the future period as the scope and its applications are rising enormously across the globe. Increasing technological innovations in liquid handling systems, rise in biotechnology and pharmaceutical companies, rising importance on data accuracy and precision, and high demand for high-throughput screening are documented as major factors of Liquid Handling Technology Market that are estimated to enhance the growth in the years to come. However, pricing limitations and economic downturn all over the world are the factors that may restrain overall market growth in the coming years. Liquid Handling Technology Market is segmented based on type, product type, application, end user, and region.

Semi-automated liquid handling, automated liquid handling, and manual liquid handling are the types that could be explored in Liquid Handling Technology in the forecast period. Exclusively used products are consumables, automated workstations, and small devices could be explored in Liquid Handling Technology in the forecast period. Consumables comprises of tubes & plates, reagents, disposable tips, and others. On the other hand, small devices comprise dispensers, pipettes, burettes, and others. Pipettes may be manual, or electronic, or controllers. The market may be categorized based on applications like biotechnology/bioprocessing, drug discovery & ADME-Tox research, cancer & genomic research, and others. End users may include contract research organization, academic & research institutes, pharmaceutical & biotechnology companies, and others that could be explored in the forecast period.

Globally, North America accounted for the largest market share of Liquid Handling Technology Industry and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be acceptance of enhanced instrumentation technology in research & development and presence of key manufacturers in the region. The United States is a major consumer of Liquid Handling Technology in this region. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share, as presence of large customer base in the form of research and academic institutes. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing investment in the life science sectors and rising developments in evolving countries. The developing countries like India and China are the major consumers of Liquid Handling Technology in the region.

The key players of Liquid Handling Technology Market are TecanTrading AG., Agilent Technologies, LABCYTE INC., Aurora Biomed Inc., Hamilton Company, Beckman Coulter Inc., Gilson Inc., Analytik Jena AG, Eppendorf AG, BioTek Instruments Inc., Labnet International Inc., and Borosil Glass Works Ltd. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Request a Sample Copy of Liquid Handling Technology Market Report @ https://www.millioninsights.com/industry-reports/liquid-handling-technology-market/request-sample

0 notes

latestmarketresearchtrends-blog · 4 years ago

Text

Liquid Handling Technology Market - Latest Innovations by Industry Experts Till 2025

Request a Sample Copy of Liquid Handling Technology Market Report @ https://www.millioninsights.com/industry-reports/liquid-handling-technology-market/request-sample

0 notes

adityarana1687-blog · 4 years ago

Text

Liquid Handling Technology Market Expected To Cross $5.54 Billion By 2025

The global liquid handling technology market is expected to reach USD 5.54 billion by 2025, according to a new report by Grand View Research, Inc. Major pharmaceutical and biopharmaceutical companies are rapidly integrating robotic solutions including automated liquid handling workstations to enhance their workflows, which in turn, is expected to drive the market growth in the coming years.

The investment by pharmaceutical companies in global drug development continues to increase. Clinical trials for the robust drug pipelines of these companies is projected to further increase the investments in R&D. These pharma players are competing to sustain the growing competition in the pharmaceutical industry. As a result, companies are more focused on eliminating errors, reducing processing steps, and fulfilling standard regulatory conditions to accelerate their workflows. As advanced liquid handling platforms provide all these benefits, demand for automated liquid handling workstations is expected to increase significantly during the forecast period.

Technology advancements in liquid handling solutions has led to the development of liquid handling systems that perform serial dilution, plate replication, PCR set-up, plate reformatting, and high-throughput screening more efficiently. Emerging fields such as genetics, epigenetics, and single cell analysis are identified with high potential applications in drug discovery, cancer research, and molecular diagnostics. Rising research activities in aforementioned domains are expected to foster advancements in this market.

Request a free sample copy or view report summary: Liquid Handling Technology Market Report

Liquid Handling Technology Market Report Highlights

Consumables accounted for the largest revenue share in 2017 owing to the high volume sales and higher market penetration

However, the entry of third-party manufacturers which provide plastic consumables such as disposable tips, compatible with automated systems at a lower cost is expected to hinder the growth of this segment to a certain extent in the coming years

Automated workstations are expected to grow at fastest pace owing to the continuous increase in complicated research projects that require sophisticated instruments

Growing trend of outsourcing pharmaceutical services to save time and resources is expected to boost the adoption of these solution in CROs

Rapid adoption of advanced genetic technologies, the high cost of hiring skilled professionals, and presence of key players are some key factors that are attributive to the largest share of North America in 2017

However, Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising interest of global companies and research communities in emerging economies of this region

Substantial economic developments in these countries has resulted into rise in investments in life science, medicine, and pharmaceutical sectors

Progress in these sectors is anticipated to propel the demand automated technology at various levels from low-to-high throughput applications in the Asian market

Some key players operating in this market include Beckman Coulter, Inc., Agilent Technologies, Eppendorf AG, Hamilton Company,

These players are involved in the development of novel technology platforms to support the changing liquid handling needs of various end users.

Liquid Handling Technology Market Segmentation

Grand View Research has segmented the global liquid handling technology market report on the basis of product, type, application, end user, and region:

Product Outlook (Revenue, USD Million; 2014 - 2025)

Automated Workstations

Small Devices

Consumables

Standalone Workstations

Integrated Workstations

Pipettes

Burettes

Dispensers

Others

Electronic Pipettes

Manual Pipettes

Pipette Controllers

Regents

Disposable Tips

Tubes & Plates

Others

Type Outlook (Revenue, USD Million; 2014 - 2025)

Automated Liquid Handling

Manual Liquid Handling

Semi-Automated Liquid Handling

Application Outlook (Revenue, USD Million; 2014 - 2025)

Drug Discovery & ADME-Tox Research

Cancer & Genomic Research

Bioprocessing/Biotechnology

Others

End User Outlook (Revenue, USD Million; 2014 - 2025)

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

Regional Outlook (Revenue, USD Million; 2014 - 2025)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

U.S.

Canada

Germany

Japan

China

Brazil

South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

#Liquid Handling Technology Market

0 notes

chitrakullkarni · 4 years ago

Text

Liquid Handling Technology Market Key Participants Examination and In-Depth Analysis Report, 2025

The global Liquid Handling Technology Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

Global Liquid Handling Technology Market is expected to reach USD 6.99 billion by 2025. Liquid Handling Technology plays important role in research laboratories for experiments like drug screening, gene sequencing, antibody testing, and protein crystallization. It includes the movement of liquid reagents through the varied range of large-scale robotic stages to hand held single channel pipettes. These are the important technologies in order to enhance accuracy and performance for the user.

Key Players:

Agilent Technologies

Aurora Biomed Inc.

AutoGen Inc.

Danaher

BioTek Instruments, Inc.

Bio-Rad Laboratories

Borosil Glass Works Ltd.

Analytik Jena AG

Corning Incorporated

Eppendorf AG

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/liquid-handling-technology-market/request-sample

Growth Drivers:

The Liquid Handling Technology Market is estimated to grow at a significant CAGR of 8.5% over the future period as the scope and its applications are rising enormously across the globe. Increasing technological innovations in liquid handling systems, rise in biotechnology and pharmaceutical companies, rising importance on data accuracy and precision, and high demand for high-throughput screening are documented as major factors of Liquid Handling Technology Market that are estimated to enhance the growth in the years to come. However, pricing limitations and economic downturn all over the world are the factors that may restrain overall market growth in the coming years.

End User Outlook:

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organization

Application Outlook:

Drug Discovery & ADME-Tox Research

Cancer & Genomic Research

Bioprocessing/Biotechnology

Type Outlook:

Automated Liquid Handling

Manual Liquid Handling

Semi-Automated Liquid Handling

Regional Outlook:

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share, as presence of large customer base in the form of research and academic institutes. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing investment in the life science sectors and rising developments in evolving countries. The developing countries like India and China are the major consumers of Liquid Handling Technology in the region.

Browse Related Category Research Reports @ https://blog.naver.com/tomclark

0 notes

millioninsights · 4 years ago

Text

Liquid Handling Technology Market Consumable products:Tubes & plates, reagents, disposable tips

Increasing technological innovations in liquid handling systems, rise in biotechnology and pharmaceutical companies, rising importance on data accuracy and precision, and high demand for high-throughput screening are documented as major factors of Liquid Handling Technology Market that are estimated to enhance the growth in the years to come. However, pricing limitations and economic downturn all over the world are the factors that may restrain overall market growth in the coming years. Liquid Handling Technology Market is segmented based on type, product type, application, end user, and region.

In-Depth research report on Liquid Handling Technology Market:

https://www.millioninsights.com/industry-reports/liquid-handling-technology-market

The market may be categorized based on applications like biotechnology/bioprocessing, drug discovery & ADME-Tox research, cancer & genomic research, and others. End users may include contract research organization, academic & research institutes, pharmaceutical & biotechnology companies, and others that could be explored in the forecast period.

To get free request sample :

https://www.millioninsights.com/industry-reports/liquid-handling-technology-market/request-sample

#Liquid Handling Technology #Biotechnology #Healthcare #healthcare services #tubes & plates #reagents #plates

0 notes

theavinashkumar · 6 years ago

Text

China bioprocess instruments market is expected to increase

When living cells Bacteria, Chloroplasts and Enzymes are used for different Bioproducts is called Bioprocess. There is different equipment available in the market for Bioprocess.

According to Hexaresearch Report, The China bioprocess instruments market is expected to owe to the improving economy, rising aging population and increasing prevalence of chronic diseases. Moreover, increasing demand for single-use instruments in disposable applications is anticipated to augment the growth over the projected period.

Full report or request for a free sample at: https://www.hexaresearch.com/research-report/china-bioprocess-instruments-market

#What is Bioprocess Instruments #Uses of Bioprocess Instruments #China Bioprocess Instruments Market

0 notes

metiresearchinfo · 3 years ago

Text

COVID-19 Impact Assessment

Click here to: Get Free Request Sample Copy of this report

Various initiatives supporting the adoption of biopharmaceuticals is projected to drive the adoption of continuous bioprocessing

Active research in the area of personalized therapies to create several opportunities for market growth

Key Findings in the Global Continuous Bioprocessing Market Study:

In 2020, the filtration systems and consumables segment accounted for the largest share of the market

The research & development segment is projected to grow at the highest CAGR during the forecast period

In 2020, the pharmaceutical and biotechnology companies segment dominated the global continuous bioprocessing market

Asia-Pacific: Fastest growing regional market

Key Players

Scope of the Report:

Continuous Bioprocessing Market, by Product

Filtration Systems and Consumables

Chromatography Systems and Consumables

Bioreactors

Sterilizers

Centrifuges

Incubators and Shakers

Mixing Systems

Cell Culture Media, Buffers, and Reagents

Other instruments and consumables

Continuous Bioprocessing Market, by Application

Commercial

R&D

Vaccines

mAb production

Recombinant Protein Production

Cell and Gene Therapy Production

Continuous Bioprocessing Market, by End User

Pharmaceutical and Biotechnology Companies

Contract Development and Manufacturing Organizations and Contract Research Organizations

Academic and Research Institutes

Continuous Bioprocessing Market, by Geography

North America

Europe

Asia-Pacific (APAC)

Latin America

Middle East & Africa

U.S.

Canada

Germany

U.K.

France

Italy

Spain

Rest of Europe (RoE)

China

Japan

India

Rest of APAC (RoAPAC)

0 notes

fmireports2020 · 4 years ago

Text

Automated Cell Culture Systems Market to Reap Excessive Revenues by 2030

According to Future Market Insights, the Automated Cell Culture Systems Market will exhibit a strong CAGR of 8% from 2020-2030.

Escalating incidences of chronic ailments have spurred greater research in cytology and cell biology for developing advanced diagnosis and treatment. This is largely an end-product of boundaries in conventional pharmaceuticals. Furthermore, growing complexities of the nature of chronic diseases is prompting various technological advancements with regard to treatment, thereby bolstering the scope of automated cell culture systems.

Greater penetration of 3D-cell cultures have significantly boosted the adoption of automated culture systems, as is the need for faster testing of biological or biochemical activities. Furthermore, requirement of cell lines to devise vaccines for COVID-19 shall catapult the automated cell culture market in the upcoming forecast period.

"Key players are developing specific and specialty growth media with the aid of various technological advancements, which is expected to sustain market growth over the following decade," infers an FMI analyst.

Key Takeaways from FMI's Automated Cell Structure Systems Report

Increasing applications of cell lines in drug discovery to heighten growth prospects

Infinite cultures to capture three-quarters of the global market share from 2020-2030

Consumables to capture 3/5th of the revenue pie, to reach US$ 11 Bn by 2030

Biotech companies shall be the primary end-users of automated cell structure systems in the coming years

North America shall surge at a CAGR of 6% through 2030, capturing over 2/5th of the market share

To get the sample copy of report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7860

Automated Cell Culture Systems Market- Key Trends

Market players push for innovative culture systems in the wake of augmented research on sera, cell culture media and reagents

Sustainable vessel solutions in packaging through the use of glass and recyclable plastic is influencing manufacturing decisions of market players

Oncology drug development is making exhaustive usage of automated cell structure systems

COVID-19 shall spur advanced research in cell lines application for drug and vaccine development, thus stimulating growth

Automated Cell Culture Systems Market- Region-wise Analysis

East Asia shall emerge as the most lucrative automated cell structure systems market. Increased healthcare infrastructure development is a key reason

North America and Europe to jointly account for 60% of the global market revenue due to the presence of a robust laboratory infrastructure

Automated Cell Culture Systems Market- Competitive Landscape

Prominent players are concentrating on offering new products, innovations and collaborations with other companies to widen their outreach across major geographical areas.

For instance, in July 2020, Sphere Fluidics announced a partnership with the Heriot-Watt University in Edinburgh for developing next generation droplet generator instrumentation. This agreement is for expanding its advanced biologics discovery and therapeutic cell line development.

Also, in February 2020, Selexis announced the application of Bioprocessing 4.0 by incorporating automated systems such as the ambr and Beacon optofluidic platforms for enhanced cell line development.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-7860

Automated Cell Culture Systems Market Taxonomy

Product Type

Automated Cell Culture Storage Equipment

Automated Cell Culture Vessels

Bioreactors

Consumables

Cell Culture Type

Finite Cell Line Cultures

Infinite Cell Line Cultures

Application

Drug Development

Stem Cell Research

Regenerative Medicine

Cancer Research

End User

Biotech Companies

Research Organizations

Academic Institutions

Region/Country

U.S

Canada

Argentina

Brazil

Mexico

Rest of LATAM

EU-5

Russia

Rest of Europe

India

Thailand

Indonesia

Malaysia

Rest of South Asia

China

Japan

South Korea

Australia

New Zealand

GCC

South Africa

Turkey

Rest of MEA

More Insights on the Automated Cell Culture Systems Market

The study provides compelling insights on automated cell culture systems market on basis of product type (automated cell culture storage equipment, automated cell culture vessels, bioreactors and consumables), cell culture type (finite cell line cultures, infinite cell line cultures), application (drug development, stem cell research, regenerative medicine and cancer research) and end user (biotech companies, research organizations, academic institutes), and across seven major regions.

#Automated Cell Culture Systems Market

0 notes

shaqibakram · 4 years ago

Text

Bioprocessing Analytics Equipment Market Forecast Report 2020 – 2027 – Top Key Players Analysis

The latest market report published by GMI Research highlights key points of market growth and industry dynamics in the coming years. The report offers a geographical analysis based on the market size. It also provides in-depth information about the leading players and the different segments of the market.

Leading Players Covered in the Bioprocessing Analytics Equipment Market are:

· Thermo Fisher Scientific Inc.

· Advanced Instruments Inc.

· F. Hoffmann-La Roche Ltd.

· Gonotec GmbH

· Resolution Spectra Systems Inc.

· ELITechGroup

· KNAUER

· Kaiser Optical Systems, Inc.

· SYSBIOTECH SARL

Key Drivers of the Bioprocessing Analytics Equipment Market:

The major factors such as the rising demand for reduced production costs in bioprocessing of therapeutic protein production and the increasing preference towards error-free batch-production has led to a surge in demand for bioprocessing equipment and bioreactors which is expected to propel the growth of the global bioprocessing analytics equipment market in the upcoming years. Moreover, the introduction of new bioprocessing analytics device with features such as integrated multi-functional bioprocessing analytics and bioprocessing data management is also anticipated to boost the growth of the bioprocessing analytics equipment market size. Food processing and tissue engineering, drug development, etc. are the emerging applications that are also projected to accelerate the demand for bioprocessing analytics equipment in the upcoming years. On the other hand, cost containment, stringent regulation, and high maintenance requirement are the key factors hindering the growth of the bioprocessing analytics equipment market.

Market Segmentation:

The report will provide a detailed analysis of the bioprocessing analytics equipment market with respect to major segments such as the name of segments. It includes the qualitative and quantitative analysis of the market during the forecast period.

Bioprocessing Analytics Equipment Market Segmentation by Product Type:

· Osmometer

o Single Sample

o Multiple Sample

· Bioprocess Analysers

o Bench Top

o Stand Alone

Bioprocessing Analytics Equipment Market Segmentation by Application Type:

· Clinical Application

· Industrial Application

Bioprocessing Analytics Equipment Market Segmentation by End-User:

· Biopharmaceutical company’s

· Contract Research Organizations (CROs)

· Contract Manufacturing Organization (CMO’s)

· Academic & Research Institutes

Bioprocessing Analytics Equipment Market Segmentation by Region:

· North America

o United States of America

o Canada

· Asia Pacific

o China

o Japan

o India

o Rest of APAC

· Europe

o United Kingdom

o Germany

o France

o Spain

o Rest of Europe

· RoW

o Brazil

o South Africa

o Saudi Arabia

o UAE

o Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is a market research and consulting firm which provides bespoke industry & market research to help businesses in making the toughest business decision. We know the significance of accurate data; that’s why our analyst use a tailored methodology to study every market in detail because one size doesn’t fit all. We not only cover the traditional well-established market but also focuses on the niche market and markets in the emerging economies, where getting data and information is a challenge. This factor makes us a pioneer in the emerging market research space. Our syndicate reports cover multiple industries across various regions and countries.

Our in-depth market reports help propel your business with all the data, strategic inputs, and competitive intelligence to move ahead even in the most uncertain times. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research look forward to help businesses stay ahead of the curve.

#Bioprocessing Analytics Equipment Market #gmiresearch

0 notes